企業プロフィール
Morphic Holding, Inc. 株価・ニュース・カタリスト
- ティッカー:
- MORF
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for MORF.
企業概要
事業概要
Morphic was an integrin-focused biotechnology company with a pipeline in inflammatory and gastrointestinal disease before being acquired by Eli Lilly.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ prior to acquisition, it sat in specialty biotechnology.
ビジネスモデルの特徴
The company was driven by novel biology, early clinical data, and the value of its integrin platform.
バイオ業界での位置付け
Morphic was a targeted immunology name and now belongs to biotech M&A history.
今後のカタリスト
- Morphic is now mostly a closeout and acquisition story after the Lilly deal, so the catalysts are integration and any remaining corporate milestone. The market is not treating it like a live standalone pipeline name anymore.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。